Sources of reliable data to continuously support claims of compliance by manufacturers will be in high demand in the future.
The Chinese government is investing heavily in the development of new technologies that leverage AI. This includes solutions to address the COVID-19 outbreak.
The latest regulations for human and veterinary medicinal products, as well as medical devices, include the mandate to set up databases with detailed information about available products. These databases must be realized and implemented in the near future, and require a concerted effort now if tangible real-world benefits are to follow.
A discussion of the changing medtech markets and how companies can remain cognizant of potentially disruptive changes in their business and industry for future success in their product portfolios, services and relationships.
Patients are demanding the same type of convenience in healthcare management as they have in the rest of their daily lives.
A more comprehensive management approach is needed to tackle the rising threat of diabetes in the region.
It’s time for medtech design engineers to take a page from the enterprise security playbook.
Designers and manufacturers of both devices and software must conduct due diligence and ensure regulatory compliance in protecting user data.
When implementing IVDR requirements, it’s important to take a step back and look at the flow of documents.
With May 26, 2020 quickly approaching, every day counts.